References
- ClowesHMScottRCHeylingsJRSkin absorption: flow-through or static diffusion cellsToxicol In Vitro19948482783020693022
- Monteiro-RiviereNAStructure and function of skinMonteiro-RiviereNAToxicology of the SkinNew YorkInforma Healthcare2010118
- BensouilahJBuckPAromadermatology: Aromatherapy in the Treatment and Care of Common Skin ConditionsLondonRadcliffe2006
- HadgraftJSkin, the final frontierInt J Pharm20012241–211811512545
- BarryBWDermatological Formulations: Percutaneous Absorption18New YorkMarcel Dekker1983
- MontagnaWParakkalPFThe Structure and Function of Skin3rd edNew YorkAcademic Press2012
- RobertsMSCrossSEPellettMAWaltersKASkin transportWaltersKADermatological and Transdermal FormulationsNew YorkMarcel Dekker200289196
- JeppsOGDancikYAnissimovYGRobertsMSModeling the human skin barrier: towards a better understanding of dermal absorptionAdv Drug Deliv Rev201365215216822525516
- DuckneyPWongHKSerranoJYaradouDOddosTStamatasGNThe role of the skin barrier in modulating the effects of common skin microbial species on the inflammation, differentiation and proliferation status of epidermal keratinocytesBMC Res Notes2013647424245826
- BoerMDuchnikEMaleszkaRMarchlewiczMStructural and biophysical characteristics of human skin in maintaining proper epidermal barrier functionPostepy Dermatol Alergol20163311526985171
- DancikYAnissimovYGJeppsOGRobertsMSConvective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical applicationBr J Clin Pharmacol201273456457821999217
- OeschFFabianEGuthKLandsiedelRXenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin modelsArch Toxicol201488122135219025370008
- LaiJMaibachHIExperimental models in predicting topical antifungal efficacy: practical aspects and challengesSkin Pharmacol Physiol200922523123919729988
- WaltersKAWatkinsonACBrainKRIn vitro skin permeation evaluation: the only realistic optionInt J Cosmet Sci199820530731618505515
- FranzTJLehmanPARaneySGUse of excised human skin to assess the bioequivalence of topical productsSkin Pharmacol Physiol200922527628619707043
- YangYMandaPPavuralaNKhanMAKrishnaiahYSDevelopment and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systemsJ Control Release2015210586625979329
- RougierALotteCMaibachHIIn vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping methodJ Pharm Sci19877664514543625489
- Sandby-MøllerJPoulsenTWulfHCEpidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habitsActa Derm Venereol200383641041314690333
- MarrakchiSMaibachHIBiophysical parameters of skin: map of human face, regional, and age-related differencesContact Dermatitis2007571283417577354
- ShrinerDLMaibachHIRegional variation of nonimmunologic contact urticaria: functional map of the human faceSkin Pharmacol1996953123218990506
- LampeMABurlingameALWhitneyJHuman stratum corneum lipids: characterization and regional variationsJ Lipid Res19832421201306833889
- KüchlerSStrüverKFriessWReconstructed skin models as emerging tools for drug absorption studiesExpert Opin Drug Metab Toxicol20139101255126323829446
- BarberoAMFraschHFEffect of Frozen human epidermis storage duration and cryoprotectant on barrier function using two model compoundsSkin Pharmacol Physiol2016291314026606593
- NielsenJBPlasenciaISørensenJABagatolliLAStorage conditions of skin affect tissue structure and subsequent in vitro percutaneous penetrationSkin Pharmacol Physiol20112429310221196813
- AbdayemRRousselLZamanNPirotFGilbertEHaftekMDeleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic moleculesExp Dermatol2015241297297426268618
- AhlstromLACrossSEMillsPCThe effects of freezing skin on transdermal drug penetration kineticsJ Vet Pharmacol Ther200730545646317803739
- MessagerSHannACGoddardPADettmarPWMaillardJYAssessment of skin viability: is it necessary to use different methodologies?Skin Res Technol20039432133014641882
- WesterRCChristoffelJHartwayTPobleteNMaibachHIForsellJHuman cadaver skin viability for in vitro percutaneous absorption: storage and detrimental effects of heat-separation and freezingPharm Res199815182849487551
- KligmanAMChristophersEPreparation of isolated sheets of human stratum corneumArch Dermatol196388670270514071437
- SanchezWYProwTWSanchezWHGriceJERobertsMSAnalysis of the metabolic deterioration of ex vivo skin from ischemic necrosis through the imaging of intracellular NAD(P)H by multiphoton tomography and fluorescence lifetime imaging microscopyJ Biomed Opt201015404600820799810
- CrossSEMagnussonBMWinckleGAnissimovYRobertsMSDetermination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layersJ Invest Dermatol2003120575976412713577
- HaighJMSmithEWThe selection and use of natural and synthetic membranes for in-vitro diffusion experimentsEur J Pharm Sci199425–6311330
- CrossSERobertsMSUse of in vitro human skin membranes to model and predict the effect of changing blood flow on the flux and retention of topically applied solutesJ Pharm Sci20089783442345018064682
- Atrux-TallauNPirotFFalsonFRobertsMSMaibachHIQualitative and quantitative comparison of heat separated epidermis and dermatomed skin in percutaneous absorption studiesArch Dermatol Res20072991050751117901965
- MagnussonBMCrossSEWinckleGRobertsMSPercutaneous absorption of steroids: determination of in vitro permeability and tissue reservoir characteristics in human skin layersSkin Pharmacol Physiol200619633634216931901
- TäuberAMüller-GoymannCCIn vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studiesInt J Pharm2015494130431126276254
- AnissimovYGRobertsMSDiffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kineticsJ Pharm Sci200493247048714705203
- AnissimovYGRobertsMSDiffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kineticsJ Pharm Sci200998277278118543296
- ZhangQLiPLiuDRobertsMSEffect of vehicles on the maximum transepidermal flux of similar size phenolic compoundsPharm Res2013301324022923350
- RaneySGFranzTJLehmanPALionbergerRChenMLPharmacokinetics-based approaches for bioequivalence evaluation of topical dermatological drug productsClin Pharmacokinet201554111095110626063051
- LehmanPAFranzTJAssessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assayPharm Res201431123529353725005736
- HadgraftJBeutnerDWolffHMIn vivo-in vitro comparisons in the transdermal delivery of nitroglycerinInt J Pharm1993891R1R4
- SkellyJPShahVPMaibachHIFDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalencePharm Res198743265267
- ShahVTopical Dermatological Drug Product NDAs and ANDAs: In Vivo Bioavailability, Bioequivalence, In Vitro Release and Associated StudiesRockville (MD)US Dept of Health and Human Services1998119
- AlbertiIKaliaYNNaikABonnyJDGuyRHIn vivo assessment of enhanced topical delivery of terbinafine to human stratum corneumJ Control Release200171331932711295224
- NicoliSBungeALDelgado-CharroMBGuyRHDermatopharmacokinetics: factors influencing drug clearance from the stratum corneumPharm Res200926486587119034629
- StenkenJAChurchMKGillCACloughGFHow minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studiesAAPS J2010121737819950008
- NarkarYBioequivalence for topical products: an updatePharm Res201027122590260120859663
- SunLStenkenJAImproving microdialysis extraction efficiency of lipophilic eicosanoidsJ Pharm Biomed Anal20033351059107114656597
- BenfeldtEHansenSHVølundAMennéTShahVPBioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic methodJ Invest Dermatol2007127117017816874309
- BodenlenzMAignerBDragatinCClinical applicability of dOFM devices for dermal samplingSkin Res Technol201319447448323581539
- GrayGYardleyHLipid compositions of cells isolated from pig, human, and rat epidermisJ Lipid Res19751664344401194786
- WesterRCMelendresJSedikLMaibachHRiviereJEPercutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivoToxicol Appl Pharmacol199815111591659705899
- JacobiUKaiserMTollRPorcine ear skin: an in vitro model for human skinSkin Res Technol2007131192417250528
- WesterRCMaibachHIIn vivo methods for percutaneous absorption measurementsJ Toxicol Cutaneous Ocul Toxicol2001204411422
- LademannJRichterHMeinkeMSterryWPatzeltAWhich skin model is the most appropriate for the investigation of topically applied substances into the hair follicles?Skin Pharmacol Physiol2010231475220090408
- CaussinJGoorisGSJanssensMBouwstraJALipid organization in human and porcine stratum corneum differs widely, while lipid mixtures with porcine ceramides model human stratum corneum lipid organization very closelyBiochim Biophys Acta2008177861472148218381060
- WertzPDowningDGoldsmithLPhysiology, Biochemistry, and Molecular Biology of the SkinOxfordOxford University Press1991
- DickIPScottRCPig ear skin as an in-vitro model for human skin permeabilityJ Pharm Pharmacol19924486406451359086
- SinghSZhaoKSinghJIn vitro permeability and binding of hydrocarbons in pig ear and human abdominal skinDrug Chem Toxicol2002251839211850972
- SatoKSugibayashiKMorimotoYSpecies differences in percutaneous absorption of nicorandilJ Pharm Sci19918021041071828835
- NicoliSPadulaCAversaVCharacterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeabilitySkin Pharmacol Physiol200821421822618509256
- LampeMAWilliamsMLEliasPMHuman epidermal lipids: characterization and modulations during differentiationJ Lipid Res19832421311406833890
- ScheupleinRJBlankIHPermeability of the skinPhysiol Rev19715147027474940637
- CaussinJGoorisGSJanssensMBouwstraJALipid organization in human and porcine stratum corneum differs widely, while lipid mixtures with porcine ceramides model human stratum corneum lipid organization very closelyBiochim Biophys Acta2008177861472148218381060
- SekkatNKaliaYNGuyRHPorcine ear skin as a model for the assessment of transdermal drug delivery to premature neonatesPharm Res20042181390139715359573
- SimonGAMaibachHIRelevance of hairless mouse as an experimental model of percutaneous penetration in manSkin Pharmacol Physiol19981128086
- BarberETeetselNMKolbergKFGuestDA comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skinFundam Appl Toxicol19921944934971426706
- ChowhanZTPritchardREffect of surfactants on percutaneous absorption of naproxen I: comparisons of rabbit, rat, and human excised skinJ Pharm Sci197867912721274690833
- HughesMFEdwardsBCIn vitro dermal absorption of pyrethroid pesticides in human and rat skinToxicol Appl Pharmacol20102461293720398685
- SchmookFPMeingassnerJGBillichAComparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorptionInt J Pharm20012151–2515611250091
- van RavenzwaayBLeiboldEA comparison between in vitro rat and human and in vivo rat skin absorption studiesHum Exp Toxicol200423942143015497817
- RobertsJBUse of squamate epidermis in percutaneous absorption studies: a reviewJ Toxicol Cutaneous Ocul Toxicol198654319324
- RiggPCBarryBWShed snake skin and hairless mouse skin as model membranes for human skin during permeation studiesJ Invest Dermatol19909422352402299198
- MegrabNAWilliamsABarryBOestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturationJ Control Release1995363277294
- Organization for Economic Co-operation and DevelopmentGuidance Notes on Dermal Absorption2011 Available from: https://www.oecd.org/chemicalsafety/testing/48532204.pdfAccessed April 25, 2016
- FlatenGEPalacZEngeslandAFilipović-GrčićJVani掊kalko-BasnetNIn vitro skin models as a tool in optimization of drug formulationEur J Pharm Sci201575102425746955
- ZhangJSunMFanAWangZZhaoYThe effect of solute-membrane interaction on solute permeation under supersaturated conditionsInt J Pharm20134411–238939423178214
- OliveiraGHadgraftJLaneMEThe role of vehicle interactions on permeation of an active through model membranes and human skinInt J Cosmet Sci201234653654522928552
- NgSFRouseJJSandersonFDEcclestonGMThe relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion studyArch Pharm Res201235457959322553050
- DabrowskaAKRotaruGMDerlerSMaterials used to simulate physical properties of human skinSkin Res Technol201622131426096898
- KansyMSennerFGubernatorKPhysicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processesJ Med Chem1998417100710109544199
- OttavianiGMartelSCarruptPAParallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeabilityJ Med Chem200649133948395416789751
- US Food and Drug AdministrationGuidance for Industry: Nonsterile Semisolid Dosage Forms Scale-Up and Postapproval Changes – Chemistry, Manufacturing, and Controls: In Vitro Release Testing and In Vivo Bioequivalence DocumentationRockville (MD)FDA1997
- ShahVPElkinsJLamSYSkellyJPDetermination of in vitro drug release from hydrocortisone creamsInt J Pharm19895315359
- WuSTShiuGKSimmonsJEBronaughRLSkellyJPIn vitro release of nitroglycerin from topical products by use of artificial membranesJ Pharm Sci19928112115311561491329
- GallagherSJTrottetLCarterTPHeardCMEffects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulationsJ Drug Target200311637337914668058
- van DrongelenVDansoMOMulderABarrier properties of an N/TERT-based human skin equivalentTissue Eng Part A20142021–223041304924819925
- BernerdFAsselineauDAn organotypic model of skin to study photodamage and photoprotection in vitroJ Am Acad Dermatol2008585 Suppl 2S155S15918410802
- Schäfer-KortingMBockUDiembeckWThe use of reconstructed human epidermis for skin absorption testing: results of the validation studyAltern Lab Anim200836216118718522484
- SchreiberSMahmoudAVuiaAReconstructed epidermis versus human and animal skin in skin absorption studiesToxicol In Vitro200519681382215913948
- van der WeydenLPattonEEWoodGACross-species models of human melanomaJ Pathol2016238215216526354726
- JinHHeROyoshiMGehaRSAnimal models of atopic dermatitisJ Invest Dermatol20091291314019078986
- SchönMPAnimal models of psoriasis: a critical appraisalExp Dermatol200817870371218557923
- ScharfenbergerLHennericiTKirályGKitzmüllerSVernooijMZielinskiJGTransgenic mouse technology in skin biology: generation of complete or tissue-specific knockout miceJ Invest Dermatol201413411524352072
- EliasPMArbiserJBrownBEEpidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasisAm J Pathol2008173368969918688025
- RossbachKSchaperKKlothCHistamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitisAllergy201671218919726440543
- BurnsEMToberKLRiggenbachJAPreventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinomaCarcinogenesis201334237037723125227
- CozziSJLeTTOgbourneSMJamesCSuhrbierAEffective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 miceArch Dermatol Res20133051798322871992
- SinghASinghASandJMTopically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomasJ Invest Dermatol201513541098110725337691
- SonavaneKPhillipsJEkshyyanOTopical curcumin-based cream is equivalent to dietary curcumin in a skin cancer modelJ Skin Cancer2012201214786323316365
- VirosAHaywardRMartinMTopical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaJ Invest Dermatol2013133127427622895366
- WangHLiJLvTTuQHuangZWangXTherapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless miceExp Dermatol201322536236323614746
- FilocamoGBrunettiMColaceciFMK-4101 – a potent inhibitor of the Hedgehog pathway – is highly active against medulloblastoma and basal cell carcinomaMol Cancer Ther20161561177118926960983
- LarsimontJCYoussefKKSanchez-DanesASox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasionCell Stem Cell2015171607326095047
- TangTTangJYLiDTargeting superficial or nodular basal cell carcinoma with topically formulated small molecule inhibitor of SmoothenedClin Cancer Res201117103378338721558397
- AvciPSadasivamMGuptaAAnimal models of skin disease for drug discoveryExpert Opin Drug Discov20138333135523293893
- Kundu-RaychaudhuriSChenYJWulffHRaychaudhuriSPKv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – xenograft modelJ Autoimmun201455637225175978
- SaltonMKasprzakWKVossTShapiroBAPoulikakosPIMisteliTInhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicingNat Commun20156710325971842
- YueLHuangZMFongSTargeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanomaMelanoma Res201525213814825643237
- ChiricozziANogralesKEJohnson-HuangLMIL-17 induces an expanded range of downstream genes in reconstituted human epidermis modelPLoS One201492e9028424587313
- TjabringaGBergersMvan RensDde BoerRLammeESchalkwijkJDevelopment and validation of human psoriatic skin equivalentsAm J Pathol2008173381582318669614
- PendariesVMalaisseJPellerinLKnockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiationJ Invest Dermatol2014134122938294624940654
- Rouaud-TinguelyPBoudierDMarchandLFrom the morphological to the transcriptomic characterization of a compromised three-dimensional in vitro model mimicking atopic dermatitisBr J Dermatol201517341006101426147950
- EngelhartKEl HindiTBiesalskiHKPfitznerIIn vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin modelsArch Dermatol Res200529711915952007
- LiLFukunaga-KalabisMHerlynMThe three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progressionJ Vis Exp201154293721847077
- MohapatraSCoppolaDRikerAIPledgerWJRoscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic melanomaMol Cancer Res20075214515117314272
- VörsmannHGroeberFWallesHDevelopment of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testingCell Death Dis201347e71923846221
- CommandeurSDrongelenVGruijlFREl GhalbzouriAEpidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinomaCancer Sci2012103122120212622974223
- LuchettiMMMoronciniGEscamezMJInduction of scleroderma fibrosis in skin-humanized mice by anti-platelet-derived growth factor receptor agonistic autoantibodiesArthritis Rheumatol Epub2016425
- KogaHNanjohYKanedaHYamaguchiHTsuboiRShort-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedisAntimicrob Agents Chemother20125663138314322391525
- AndersenFHedegaardKPetersenTKBindslev-JensenCFullertonAAndersenKEThe hairless guinea-pig as a model for treatment of cumulative irritation in humansSkin Res Technol2006121606716420540
- SchröderHKomljenovicDHeckerMKorffTTransdermal drug targeting and functional imaging of tumor blood vessels in the mouse auricleFASEB J201630292393226546130
- ChenYWuQZhangZYuanLLiuXZhouLPreparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamicsMolecules20121755972598722609787
- YuXDuLZhuLMelanoma therapy with transdermal mitoxantrone cubic phasesDrug Deliv20162351565157025835224